iCAN Digital Precision Cancer Medicine Flagship

News

Event: Welcome to join iCAN Health TV

Cutting-edge cancer research builds on the best data in the world Health Capital Helsinki Health TV introduces iCAN and how it leverages the best health data and the most advanced hospital data …

News

Kari Alitalo has been conferred the honorary title of Academician of Science

iCAN Scientific Director Kari Alitalo has been conferred the honorary title of Academician of Science by President Sauli Niinistö on 27th November 2020. This honorary title is been conferred on …

News

Introducing the iCAN Scientific and Impact Advisory Board

The Scientific and Impact Advisory Board (SIAB) provides statements and recommendations to iCAN on scientific matters and also on making an impact for patients and partners. The first meeting is scheduled …

News

Digital booklet on the Finnish offering of cancer research and care

Business Finland has released a digital booklet on the Finnish offering of cancer research and care. Finland is at the forefront in cancer research and treatment, with expertise ranging from research, treatment and digital tools for both …

Yleinen

Request for proposals to be integrated into the iCAN Flagship Project 2021-22

An important part of the iCAN national R&D flagship is the initiating iCAN Flagship Project (FP) linking deep molecular profiling with deep clinical and health data from 15 000 patients …

News

HUS Tutkimusraatien ensimmäinen koulutus

HUS Tutkimusraatien ensimmäinen koulutuspäivä järjestettiin maanantaina 21.9.2020. Koulutuksessa oli mukana noin 50 HUSin asiakasraatien sekä iCAN Potilasneuvottelukunnan jäsentä. Asiakasraadit ovat toimineet HUSissa jo usean vuoden ajan kehittäen potilaslähtöistä hoitokulttuuria ja …

News

Finalists of Cancer Challenge at European R&D Days 2020

Winner of the Cancer Challenge, Eva-Maria Strömsholm and first runner up, Mikko Viitanen presented their ideas on open European Research & Innovation Days online event on 24.9.2020. Hub 5: Horizon …

News

iCANin potilasyhteistyö jatkuu aktiivisena

iCANin Potilas- ja kansalaisvaikuttamisen neuvottelukunta (POTKU) piti toisen varsinaisen kokouksensa perjantaina 28.8. Potilaan osallisuus ja potilasjärjestöt ovat iCAN-lippulaivassa merkittävässä roolissa. Tavoitteena on, että potilaat ovat aktiivisesti mukana tutkimusten suunnittelussa ja …

News

VEIL.AI joins iCAN for opportunities in health data anonymization

The sensitive health data startup VEIL.AI joins the iCAN Digital Precision Cancer Medicine competence cluster to find opportunities in anonymizing complex cancer patient data. The membership agreement to the iCAN …

News

iCAN Science Webinars 2020

iCAN collaborated with Biomedicum Helsinki Seminars, as BMH seminars were arranged as webinars spring 2020. Suggest a speaker for iCAN Science webinars for autumn 2020 by contacting ican@helsinki.fi. Previous webinars “Emergence …

Read Our Tweets

About

The challenge of our time

Cancer is a growing threat to our global health. The scientific community and society at large are investing heavily to improve prevention, detection, survival, and quality of life of cancer patients. Precision Cancer Medicine represents a highly promising approach to tackle this global challenge, but there are still a number of bottlenecks.

Our approach

Combining precision cancer medicine and digital health.
Our approach is based on integrating molecular data with digital health data in new and meaningful ways. Sounds quite straight forward, right? But rest assured, it is a highly challenging task. The good news is that Finland has globally unique assets for actually making this happen.

For patients

Improved treatments and quality of life for cancer patients through innovative research – empowerment by working together.

For researchers

Bring your skills to iCAN to enable breakthrough science at the intersection of precision cancer medicine and digital health.

For partners

Join iCAN competence cluster to contribute and impact how the digital precision cancer medicine goes for solutions.

Empowering patients in cancer care and research

Partners

Introducing iCAN

iCAN is an innovative multidisciplinary initiative
that brings together some of the world’s leading actors in cancer genomics,
translational and clinical cancer research, digital health, information technology,
machine learning and business to solve one of the most pressing challenges of our time – cancer.
This unique ecosystem will be based on two national cancer research Centers of Excellence
at the University of Helsinki and the first Nordic Comprehensive Cancer Center at Helsinki University Hospital HUS with an aim to synergize with the national cancer center FICAN and its regional node FICAN South.

Join the iCAN community

iCAN is still forming its ways to operate, and therefore…

We would really appreciate your input either here or at our upcoming events. As presented at the kick-off May 29, we are currently developing engagement opportunities for companies to join and would be very interested in discussing this with you.

Contact

iCAN@helsinki.fi